Presentation ACC 2023 Transcatheter vs Surgical Aortic Valve Replacement in Low RiskPatients: 3-Year Outcomes from the EvolutLow Risk Trial Presenter: John K. Forrest March 05, 2023
Presentation ACC 2019 Primary Results From the Evolut Low Risk Trial Presenter: Michael J. Reardon March 17, 2019